Found: 23
Select item for more details and to access through your institution.
Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 9, p. 2092
- By:
- Publication type:
- Article
Starting or Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Clinical Practice: Pooled 12-month (12M) Results from the Global BICSTaR Study.
- Published in:
- Mediterranean Journal of Infection, Microbes & Antimicrobials, 2021, p. 131
- By:
- Publication type:
- Article
Efficacy and Safety of Switching to Dolutegravir With Boosted Darunavir in Virologically Suppressed Adults With HIV-1: A Randomized, Open-Label, Multicenter, Phase 3, Noninferiority Trial: The DUALIS Study.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 9, p. 1, doi. 10.1093/ofid/ofaa356
- By:
- Publication type:
- Article
Intermittent viraemia and immune reconstitution in patients with more than 10-15 years of antiretroviral therapy: baseline values still matter.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19689
- By:
- Publication type:
- Article
Everything fine so far? Physical and mental health in HIV-infected patients with virological success and long-term exposure to antiretroviral therapy.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19673
- By:
- Publication type:
- Article
HIV pre-exposure prophylaxis was associated with no impact on sexually transmitted infection prevalence in a high-prevalence population of predominantly men who have sex with men, Germany, 2018 to 2019.
- Published in:
- Eurosurveillance (15607917), 2022, v. 27, n. 14, p. 19, doi. 10.2807/1560-7917.ES.2022.27.14.2100591
- By:
- Publication type:
- Article
Factors associated with testing for HIV and hepatitis C among behaviorally vulnerable men in Germany: a cross-sectional analysis upon enrollment into an observational cohort.
- Published in:
- AIDS Research & Therapy, 2021, v. 18, n. 1, p. 1, doi. 10.1186/s12981-021-00378-4
- By:
- Publication type:
- Article
High effectiveness of recommended first-line antiretroviral therapies in Germany: a nationwide, prospective cohort study.
- Published in:
- Infection, 2020, v. 48, n. 3, p. 453, doi. 10.1007/s15010-020-01428-1
- By:
- Publication type:
- Article
Treatment Extension of Pegylated Interferon Alpha and Ribavirin Does Not Improve SVR in Patients with Genotypes 2/3 without Rapid Virological Response (OPTEX Trial): A Prospective, Randomized, Two-Arm, Multicentre Phase IV Clinical Trial.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0128069
- By:
- Publication type:
- Article
Predictive Factors for Sustained Virological Response after Treatment with Pegylated Interferon α-2a and Ribavirin in Patients Infected with HCV Genotypes 2 and 3.
- Published in:
- PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0107592
- By:
- Publication type:
- Article
HIV and Cancer in Germany.
- Published in:
- 2011
- By:
- Publication type:
- Abstract
HIV and Cancer in Germany.
- Published in:
- Deutsches Ärzteblatt International, 2011, v. 108, n. 8, p. 117, doi. 10.3238/arztebl.2010.0117
- By:
- Publication type:
- Article
Auffällige Zunahme des Lymphogranuloma venereum unter homosexuellen Männern in Hamburg.
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2004, v. 2, n. 8, p. 676, doi. 10.1046/j.1439-0353.2004.04702.x
- By:
- Publication type:
- Article
Glecaprevir/pibrentasvir is safe and effective in hepatitis C patients with cirrhosis: Real‐world data from the German Hepatitis C‐Registry.
- Published in:
- Liver International, 2021, v. 41, n. 5, p. 949, doi. 10.1111/liv.14829
- By:
- Publication type:
- Article
Real-World Safety, Effectiveness, and Patient-Reported Outcomes in Patients with Chronic Hepatitis C Virus Infection Treated with Glecaprevir/Pibrentasvir: Updated Data from the German Hepatitis C-Registry (DHC-R).
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 7, p. N.PAG, doi. 10.3390/v14071541
- By:
- Publication type:
- Article
Prognostic impact of steatosis in the clinical course of chronic HCV infection—Results from the German Hepatitis C-Registry.
- Published in:
- PLoS ONE, 2022, v. 17, n. 6, p. 1, doi. 10.1371/journal.pone.0264741
- By:
- Publication type:
- Article
Adoptive transfer of syngeneic T cells in HIV-1 discordant twins indicates rapid regulation of T-cell homeostasis.
- Published in:
- British Journal of Haematology, 2007, v. 136, n. 4, p. 641, doi. 10.1111/j.1365-2141.2006.06478.x
- By:
- Publication type:
- Article
research paper Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin's disease.
- Published in:
- British Journal of Haematology, 2004, v. 125, n. 4, p. 455, doi. 10.1111/j.1365-2141.2004.04934.x
- By:
- Publication type:
- Article
The changing characteristics of patients infected with chronic hepatitis C virus from 2014 to 2019: Real‐world data from the German Hepatitis C‐Registry (DHC‐R).
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 10, p. 1474, doi. 10.1111/jvh.13586
- By:
- Publication type:
- Article
Real‐world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C infection: data from the German Hepatitis C‐Registry.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 49, n. 8, p. 1052, doi. 10.1111/apt.15222
- By:
- Publication type:
- Article
Real-world effectiveness and safety of sofosbuvir/velpatasvir and ledipasvir/sofosbuvir hepatitis C treatment in a single centre in Germany.
- Published in:
- PLoS ONE, 2019, v. 14, n. 4, p. 1, doi. 10.1371/journal.pone.0214795
- By:
- Publication type:
- Article
Outcomes of men with HIV and germ cell cancer: Results from an international collaborative study.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 2, p. 260, doi. 10.1002/cncr.33928
- By:
- Publication type:
- Article
Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study).
- Published in:
- AIDS Research & Therapy, 2019, v. 16, n. 1, p. N.PAG, doi. 10.1186/s12981-019-0250-2
- By:
- Publication type:
- Article